Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa

Vaccine

Volumn 30, Issue SUPPL.3, 2012, Pages

  Schoub, Barry D ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Endgame planning; Herd immunity; Inactivated polio vaccine; Mucosal immunity; Oral polio vaccine; Pentavalent vaccine; Vaccine associated paralytic polio

Indexed keywords

IMMUNOGLOBULIN A; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG SAFETY; ERADICATION THERAPY; GROUPS BY AGE; HEALTH PROGRAM; HEALTH PROMOTION; HERD IMMUNITY; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; TREATMENT PLANNING;

HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; SOUTH AFRICA; VACCINATION;

EID: 84865630807     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.056     Document Type: Review

References (23)

1. Schoub B.D., Chezzi C., Blackburn N.K. Last virologically confirmed cases of wild-type poliomyelitis in South Africa. S Afr Med J 1995, 85(1):55.
2. Van Middelkoop A., van Wyk J.E., Küstner H.G.V., Windsor I., Vinsen C., Schoub B.D., et al. Poliomyelitis outbreak in Natal/KwaZulu, South Africa, 1987-1988. I. Epidemiology. Trans R Soc Trop Med Hyg 1992, 86:83-85.
3. World Health Organization. Polio reported in Botswana. (last access 23/03/2011). http://www.who.int/mediacentre/news/notes/2004/np11/en/.
4. Van Niekerk A.B.W., Vries J.B., Baard J., Schoub B.D., Blackburn N.K. Outbreak of paralytic poliomyelitis in Namibia. Lancet 1994, 344:661-664.
5. Centers for Disease Control and Prevention (CDC) Outbreaks following wild poliovirus importations - Europe, Africa, and Asia, January 2009-September 2010. MMWR Morb Mortal Wkly Rep 2010, 59(November (43)):1393-1399.
6. Centers for Disease Control and Prevention (CDC) Progress toward interrupting wild poliovirus circulation in countries with reestablished transmission - Africa, 2009-2010. MMWR Morb Mortal Wkly Rep 2011, 60(March (10)):306-311.
7. World Health Organization Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec 2010, 85(June (23)):213-228.
8. 2nd Meeting of the Working Group on Pre- and Post-Polio Eradication Issues, Brazzaville, Congo - 13 and 14 August 2008, WHO African Regional Office, Brazzaville.
9. Second Meeting of the SAGE Working Group on IPV. 3 and 4 June 2009. Geneva: WHO. http://www.who.int/immunization/sage/3_IPV_WG_NFR_2nd_Mtg_June_09version_Oct8.pdf.
10. Robertson S.E., Traverso H.P., Drucker J.A., Rovira E.Z., Fabre-Teste B., Sow A., et al. Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine. Lancet 1988, 1(April (8591)):897-899.
11. Cuba IPV Study Collaborative Group Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N Engl J Med 2007, 356(April (15)):1536-1544.
12. World Health Organization Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Bull World Health Organ 1996, 74(3):253-268.
13. von Magnus H., Petersen I. Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark. Rev Infect Dis 1984, 6(May-June (Suppl. 2)):S471-S474.
14. Herremans T.M., Reimerink J.H., Buisman A.M., Kimman T.G., Koopmans M.P. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J Immunol 1999, 162(April (8)):5011-5018.
15. Tulchinsky T., Abed Y., Shaheen S., Toubassi N., Sever Y., Schoenbaum M., et al. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Am J Public Health 1989, 79(December (12)):1648-1652.
16. Goldblum N., Gerichter C.B., Tulchinsky T.H., Melnick J.L. Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area. Bull World Health Organ 1994, 72(5):783-796.
17. Swartz T.A., Green M.S., Handscher R., Sofer D., Cohen-Dar M., Shohat T., et al. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel. Vaccine 2008, 26(February (8)):1083-1090. [Epub 2008 January 7].
18. Parent du Châtelet I., Merchant A.T., Fisher-Hoch S., Luby S.P., Plotkin S.A., Moatter T., et al. Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules. Vaccine 2003, 21(April (15)):1710-1718.
19. Griffiths U.K., Botham L., Schoub B.D. The cost-effectiveness of alternative polio immunization policies in South Africa. Vaccine 2006, 24(July (29-30)):5670-5678.
20. World Health Organization. WHO vaccine-preventable diseases: monitoring system 2010 global summary. http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileresults.
21. World Health Organization Progress towards eradicating poliomyelitis in India, January 2009-October 2010. Wkly Epidemiol Rec 2010, 85(December (50)):497-503.
22. Kohler K.A., Banerjee K., Gary Hlady W., Andrus J.K., Sutter R.W. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Bull World Health Organ 2002, 80(3):210-216.
23. The World Bank. http://data.worldbank.org/country/southafrica.